Annual Cash & Cash Equivalents
$48.51 M
-$3.10 M-6.01%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual cash & cash equivalents is $48.51 million, with the most recent change of -$3.10 million (-6.01%) on December 31, 2023.
- During the last 3 years, CUE annual cash & cash equivalents has fallen by -$26.35 million (-35.20%).
- CUE annual cash & cash equivalents is now -35.20% below its all-time high of $74.87 million, reached on December 31, 2020.
Performance
CUE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$32.42 M
+$2.39 M+7.96%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly cash and cash equivalents is $32.42 million, with the most recent change of +$2.39 million (+7.96%) on September 30, 2024.
- Over the past year, CUE quarterly cash and cash equivalents has increased by +$2.39 million (+7.96%).
- CUE quarterly cash and cash equivalents is now -56.70% below its all-time high of $74.87 million, reached on December 31, 2020.
Performance
CUE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CUE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | +8.0% |
| 3 y3 years | -35.2% | -37.2% |
| 5 y5 years | +133.2% | -37.2% |
CUE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | at low | -52.3% | +9.1% |
| 5 y | 5-year | -35.2% | +9.5% | -56.7% | +38.4% |
| alltime | all time | -35.2% | +657.4% | -56.7% | +853.4% |
Cue Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $32.42 M(+8.0%) |
| Jun 2024 | - | $30.03 M(-26.8%) |
| Mar 2024 | - | $41.03 M(-15.4%) |
| Dec 2023 | $48.51 M(-6.0%) | $48.51 M(-11.3%) |
| Sep 2023 | - | $54.69 M(+3.4%) |
| Jun 2023 | - | $52.90 M(-6.1%) |
| Mar 2023 | - | $56.32 M(+9.1%) |
| Dec 2022 | $51.61 M(-19.8%) | $51.61 M(+73.6%) |
| Sep 2022 | - | $29.73 M(-55.0%) |
| Jun 2022 | - | $66.13 M(-2.7%) |
| Mar 2022 | - | $67.93 M(+5.5%) |
| Dec 2021 | $64.37 M(-14.0%) | $64.37 M(-4.8%) |
| Sep 2021 | - | $67.63 M(-8.5%) |
| Jun 2021 | - | $73.92 M(+0.9%) |
| Mar 2021 | - | $73.26 M(-2.1%) |
| Dec 2020 | $74.87 M | $74.87 M(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $71.73 M(+20.1%) |
| Jun 2020 | - | $59.75 M(+155.0%) |
| Mar 2020 | - | $23.43 M(-47.1%) |
| Dec 2019 | $44.29 M(+112.9%) | $44.29 M(+41.1%) |
| Sep 2019 | - | $31.38 M(+29.3%) |
| Jun 2019 | - | $24.26 M(+10.7%) |
| Mar 2019 | - | $21.91 M(+5.3%) |
| Dec 2018 | $20.80 M(-67.3%) | $20.80 M(+31.3%) |
| Sep 2018 | - | $15.84 M(-65.4%) |
| Jun 2018 | - | $45.74 M(-13.9%) |
| Mar 2018 | - | $53.10 M(-16.4%) |
| Dec 2017 | $63.53 M(+325.7%) | $63.53 M(+1768.4%) |
| Sep 2017 | - | $3.40 M(-53.5%) |
| Jun 2017 | - | $7.31 M(-51.0%) |
| Dec 2016 | $14.93 M(+133.0%) | $14.93 M |
| Dec 2015 | $6.41 M | - |
FAQ
- What is Cue Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cue Biopharma?
- What is Cue Biopharma annual cash & cash equivalents year-on-year change?
- What is Cue Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cue Biopharma?
- What is Cue Biopharma quarterly cash and cash equivalents year-on-year change?
What is Cue Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of CUE is $48.51 M
What is the all time high annual cash & cash equivalents for Cue Biopharma?
Cue Biopharma all-time high annual cash & cash equivalents is $74.87 M
What is Cue Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, CUE annual cash & cash equivalents has changed by -$3.10 M (-6.01%)
What is Cue Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CUE is $32.42 M
What is the all time high quarterly cash and cash equivalents for Cue Biopharma?
Cue Biopharma all-time high quarterly cash and cash equivalents is $74.87 M
What is Cue Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, CUE quarterly cash and cash equivalents has changed by +$2.39 M (+7.96%)